I asked my neurologist if I should get Covid booster or full dose(pharmacy questioned me so I asked) here is her response.
You can get the normal booster.
After 2 weeks from the booster we can schedule you for another new treatment designed for patients with immunosupression called EVUSHELD. This has a good amount of antibodies against the virus infection protective for 6 mo.It is done in clinic by 2 intramuscular injections. Please, review the info below and see if you are interested to get this treatment. We started injecting the patients for 2 weeks now.
You will be given a medicine called EVUSHELD (tixagevimab co-packaged with cilgavimab). It is an investigational medicine used to for preexposure prophylaxis for prevention of COVID-19 in persons who are not currently infected with SARS-CoV-2 and who have not had recent known close contact with someone who is infected with SARS-CoV-2 AND who have moderate to severe immune compromise due to a medical condition or have received immunosuppressive medicines and may not mount an adequate immune response to COVID-19 vaccination OR for whom vaccination with any available COVID-19 vaccine is not recommended due to a history of severe allergic reaction to a COVID-19 vaccine(s) or vaccine ingredient(s).
EVUSHELD is investigational because it is still being studied. EVUSHELD has not undergone the same type of review as an FDA-approved product. There is limited information known about the safety and effectiveness of using EVUSHELD to prevent COVID-19. However, the FDA has authorized the emergency use of EVUSHELD for pre-exposure prophylaxis for prevention of COVID-19 under an Emergency Use Authorization (EUA). Under section 564 of the Federal Food, Drug, and Cosmetic Act (FD&C Act), when the Secretary of HHS declares that an EUA is appropriate, FDA may authorize unapproved medical products or unapproved uses of approved medical products to be used in an emergency to diagnose, treat, or prevent serious or life-threatening diseases when certain criteria are met, including there are no adequate, approved, and available alternatives.